Clinical Trial Update: A Pilot Study Testing the Safety and Feasibility of Restorative Microbiota Therapy (RMT) in Patients With Refractory Immune-checkpoint Inhibitor-related Colitis [Phase 2]

View source ↗

Summary

A Phase 2 pilot study evaluating the safety and feasibility of Restorative Microbiota Therapy for refractory immune-checkpoint inhibitor–related colitis has bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colitis
• Immune-related Colitis

Drugs mentioned

• Restorative Microbiota Therapy (RMT)

Snippet

Sponsor: University of Minnesota | Conditions: Immune-related Colitis, Colitis | Phase 2 | Status: WITHDRAWN